AAAAAA
Results:
1-15
|
Results: 15
Authors:
Berstad, A
Olafsson, S
Tefera, S
Hatlebakk, JG
Gilja, OH
Hausken, T
Citation: A. Berstad et al., Controversies in dyspepsia, EURO J SURG, 167, 2001, pp. 4-11
Authors:
Lundell, L
Miettinen, P
Myrvold, HE
Pedersen, SA
Liedman, B
Hatlebakk, JG
Julkonen, R
Levander, K
Carlsson, J
Lamm, M
Wiklund, I
Citation: L. Lundell et al., Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease, J AM COLL S, 192(2), 2001, pp. 172-179
Authors:
Tefera, S
Gilja, OH
Hatlebakk, JG
Berstad, A
Citation: S. Tefera et al., Gastric accommodation studied by ultrasonography in patients with reflux esophagitis, DIG DIS SCI, 46(3), 2001, pp. 618-625
Authors:
Tefera, S
Hatlebakk, JG
Berstad, A
Citation: S. Tefera et al., Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease, AM J GASTRO, 96(4), 2001, pp. 969-974
Authors:
Hatlebakk, JG
Berstad, A
Madsen, PH
Walle, PO
Citation: Jg. Hatlebakk et al., Heartburn treatment in primary care - Reply, BR MED J, 320(7246), 2000, pp. 1407-1407
Authors:
Lundell, L
Miettinen, P
Myrvold, HE
Pedersen, SA
Thor, K
Lamm, M
Blomqvist, A
Hatlebakk, JG
Janatuinen, E
Levander, K
Nystrom, P
Wiklund, I
Citation: L. Lundell et al., Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial, EUR J GASTR, 12(8), 2000, pp. 879-887
Authors:
Katz, PO
Hatlebakk, JG
Castell, DO
Citation: Po. Katz et al., Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole, ALIM PHARM, 14(6), 2000, pp. 709-714
Authors:
Hatlebakk, JG
Katz, PO
Camacho-Lobato, L
Castell, DO
Citation: Jg. Hatlebakk et al., Proton pump inhibitors: better acid suppression when taken before a meal than without a meal, ALIM PHARM, 14(10), 2000, pp. 1267-1272
Authors:
Hatlebakk, JG
Hyggen, A
Madsen, PH
Walle, PO
Schulz, T
Mowinckel, P
Bernklev, T
Berstad, A
Citation: Jg. Hatlebakk et al., Heartburn, treatment in primary care: randomised, double blind study for 8weeks, BR MED J, 319(7209), 1999, pp. 550-553
Authors:
Hatlebakk, JG
Katz, PO
Castell, DO
Citation: Jg. Hatlebakk et al., Medical therapy - Management of the refractory patient, GASTRO CLIN, 28(4), 1999, pp. 847
Authors:
Wilhelmsen, I
Hatlebakk, JG
Olafsson, S
Berstad, A
Citation: I. Wilhelmsen et al., On demand therapy of reflux oesophagitis - a prospective study of symptoms, patient satisfaction and quality of life, ALIM PHARM, 13(8), 1999, pp. 1035-1040
Authors:
Tefera, S
Hatlebakk, JG
Berstad, A
Citation: S. Tefera et al., The effect of Helicobacter pylori eradication on gastro-oesophageal reflux, ALIM PHARM, 13(7), 1999, pp. 915-920
Authors:
Olafsson, S
Berstad, A
Bang, CJ
Nysaeter, G
Coll, P
Tefera, S
Hatlebakk, JG
Hausken, T
Olafsson, T
Citation: S. Olafsson et al., Spiramycin is comparable to oxytetracycline in eradicating H-pylori when given with ranitidine bismuth citrate and metronidazole, ALIM PHARM, 13(5), 1999, pp. 651-659
Authors:
Fouad, YM
Katz, PO
Hatlebakk, JG
Castell, DO
Citation: Ym. Fouad et al., Ineffective esophageal motility: The most common motility abnormality in patients with GERD-associated respiratory symptoms, AM J GASTRO, 94(6), 1999, pp. 1464-1467
Authors:
Hatlebakk, JG
Katz, PO
Kuo, B
Castell, DO
Citation: Jg. Hatlebakk et al., Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily, ALIM PHARM, 12(12), 1998, pp. 1235-1240
Risultati:
1-15
|